Literature DB >> 11443178

Postprandial remnant-like lipoproteins in hypertriglyceridemia.

T C Ooi1, M Cousins, D S Ooi, G Steiner, K D Uffelman, K Nakajima, I E Simo.   

Abstract

It has been proposed that remnants of chylomicrons and very-low-density lipoproteins (VLDL) are atherogenic. We have used an immunochemical method to isolate remnant-like particles (RLP) and measured them in terms of their cholesterol and triglycerides (TG). RLP consist of apoB-48-containing triglyceride-rich lipoproteins and remnant-like VLDL containing apoB-100. The study aim was to look for information from postprandial RLP data that could not be known from other markers of triglyceride-rich lipoproteins and fasting TG and RLP data alone. A total of 41 subjects were studied. Eight subjects had hypertriglyceridemia (HTG) and low high-density lipoprotein (HDL), 14 had combined hyperlipidemia (CH), 5 had the apo E2/2 genotype receiving gemfibrozil, 10 were normolipidemic (NL) controls, and 4 had hypercholesterolemia. As a whole group, there was correlation among 1) fasting TG, RLP cholesterol (RLP-C), and RLP-TG but not VLDL apo B100, VLDL apo B48 and their respective postprandial responses measured as incremental area under the curve (IAUC), 2) fasting TG and postprandial IAUC of RLP-C and RLP-TG, 3) RLP-C IAUC, RLP-TG IAUC, and TG IAUC, retinyl palmitate (RP) IAUC, and VLDL apo B48 IAUC but not VLDL apo B100 IAUC. The HTG/low HDL-C and CH groups had higher IAUC for RLP-C, RLP-TG, TG, and RP than the NL group. Fasting and postprandial RLP were triglyceride enriched in the HTG/low HDL-C group and to a lesser extent in the CH group. The HTG/low HDL-C and CH groups had a delay in their RLP-C but not RLP-TG peaks suggesting a delay in hepatic clearance of RLP and/or a protracted period of lipolysis and/or processing of RLP. The fasting and postprandial RLP-C/RLP-TG and RLP-C/TG ratios were elevated in the apo E2/2 group in spite of gemfibrozil therapy. The increment in postprandial RLP was, however, not exaggerated. Our data indicate that 1) postprandial RLP lipemia is enhanced in HTG subjects when compared with NL subjects, 2) postprandial RLP lipemia is proportional to fasting RLP and TG levels and mirrors, to a large extent, increases in postprandial TG, RP, and VLDL apo B48 but not VLDL apo B100, 3) there are compositional differences in fasting and postprandial RLP in the three forms of HTG studied, RLP being triglyceride enriched in the HTG/low HDL-C group and to a lesser extent in the CH group, and cholesterol-enriched in the apo E2/2 group, and 4) apo E2/2 subjects had high fasting and postprandial RLP-C concentrations in spite of being on treatment with gemfibrozil and having normal fasting and postprandial TG concentrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443178     DOI: 10.1210/jcem.86.7.7627

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

Review 2.  Remnant lipoproteins and atherosclerosis.

Authors:  ThB Twickler; G M Dallinga-Thie; M J Chapman; J S Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

3.  Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy.

Authors:  Erdembileg Anuurad; Asha Thomas-Geevarghese; Sridevi Devaraj; Jeanine Albu; Robert Minolfo; Wafaa M El-Sadr; Guijing Lu; Wahida Karmally; Lars Berglund
Journal:  Atherosclerosis       Date:  2007-11-09       Impact factor: 5.162

4.  Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.

Authors:  Pablo Pérez-Martínez; Francisco Pérez-Jiménez; José María Ordovás; Juan Antonio Moreno; Carmen Marín; Rafael Moreno; Yolanda Jiménez-Gómez; Juan Antonio Paniagua; José López-Miranda
Journal:  Lipids       Date:  2007-02-10       Impact factor: 1.880

5.  The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Hyun Duk Moon; Takeaki Nagamine; Kimber L Stanhope; Peter J Havel; G Russell Warnick
Journal:  Clin Chim Acta       Date:  2009-04-01       Impact factor: 3.786

6.  Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.

Authors:  Robert S Rosenson; Terry A Jacobson; David Preiss; C Stephen Djedjos; Ricardo Dent; Ian Bridges; Michael Miller
Journal:  Cardiovasc Drugs Ther       Date:  2016-06       Impact factor: 3.727

7.  Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjects.

Authors:  M A Larsen; R Goll; S Lekahl; O S Moen; J Florholmen
Journal:  Clin Obes       Date:  2015-10-15

8.  Assessment of the Validity and Reproducibility of a Novel Standardized Test Meal for the Study of Postprandial Triacylglycerol Concentrations.

Authors:  Nikolaos Tentolouris; Panagiotis T Kanellos; Evangelia Siami; Elpida Athanasopoulou; Nikolaos Chaviaras; Genovefa Kolovou; Petros P Sfikakis; Nikolaos Katsilambros
Journal:  Lipids       Date:  2017-06-26       Impact factor: 1.880

9.  Low fasting low high-density lipoprotein and postprandial lipemia.

Authors:  Genovefa D Kolovou; Katherine K Anagnostopoulou; Nektarios Pilatis; Nikolaos Kafaltis; Konstandina Sorodila; Eleftherios Psarros; Dennis V Cokkinos
Journal:  Lipids Health Dis       Date:  2004-07-23       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.